Numerous molecular mechanisms could explain the link between NSAIDs and cancer prevention, such as COX inhibition, immune response, PI3K/Akt pathway downregulation, pro-inflammatory response, and decreased glycolytic signaling in tumor cells [22,33]. This evidence concerns the gene AKT1 and neoplasm.